The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer
- 1 March 1992
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 57 (3) , 597-600
- https://doi.org/10.1016/s0015-0282(16)54906-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mechanisms and factors of early pregnancy wastage in in vitro fertilization-embryo transfer patientsFertility and Sterility, 1988
- β-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patientsFertility and Sterility, 1988
- Preclinical abortions and endometriosisFertility and Sterility, 1988
- Spontaneous abortion and endometriosisFertility and Sterility, 1987
- Association of endometriosis and spontaneous abortion: effect of control group selectionFertility and Sterility, 1986
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Endometriosis and spontaneous abortionFertility and Sterility, 1984
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- The relationship of endometriosis to spontaneous abortionFertility and Sterility, 1983
- Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilizationFertility and Sterility, 1983